Q3 2017 Holdings
Filed 2017-11-03 | 5 holdings | $299.0K | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Seres Therapeutics Inc(MCRB1EUR) | COM | 81750R102 | $203.4K | 12,682,876 | 68.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $47.2K | 3,204,437 | 15.8% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $40.2K | 1,674,435 | 13.4% |
| T2 Biosystems Inc | COM | 89853L104 | $8.2K | 1,950,583 | 2.7% |